Depression as a modifiable factor to decrease the risk of dementia

Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 41: 615–631.

Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F . New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease modifying drugs. Br J Clin Pharmacol 2012; 73: 504–517.

Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C . Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol 2014; 13: 788–794.

Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300: 1027–1037.

Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385: 2255–2263.

Moll van Charante EP, Richard E, Eurelings LS, van Dalen JW, Ligthart SA, van Bussel EF et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet 2016; 388: 797–805.

Prince M, Wilmo A, Guerchet M, Ali G, Wu Y, Prina M World Alzheimer Report 2015: the Global Impact of Dementia: an Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer’s Disease International: London, 2015.

Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd . Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013; 202: 329–335.

Gracia-Garcia P, de-la-Camara C, Santabarbara J, Lopez-Anton R, Quintanilla MA, Ventura T et al. Depression and incident Alzheimer disease: the impact of disease severity. Am J Geriatr Psychiatry 2015; 23: 119–129.

Zeki Al Hazzouri A, Vittinghoff E, Byers A, Covinsky K, Blazer D, Diem S et al. Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women. J Gerontol A Biol Sci Med Sci 2014; 69: 595–601.

Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier H et al. 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry 2016; 3: 628–635.

Kaup AR, Byers AL, Falvey C, Simonsick EM, Satterfield S, Ayonayon HN et al. Trajectories of depressive symptoms in older adults and risk of dementia. JAMA Psychiatry 2016; 73: 525–531.

Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000; 157: 1949–1954.

Beats BC, Sahakian BJ, Levy R . Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 1996; 26: 591–603.

Taylor WD, McQuoid DR, Payne ME, Zannas AS, MacFall JR, Steffens DC . Hippocampus atrophy and the longitudinal course of late-life depression. Am J Geriatr Psychiatry 2014; 22: 1504–1512.

Verhoeven JE, Revesz D, Epel ES, Lin J, Wolkowitz OM, Penninx BW . Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry 2014; 19: 895–901.

Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K . Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol 2009; 38: 48–52.

Crum RM, Anthony JC, Bassett SS, Folstein MF . Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993; 269: 2386–2391.

Holman CD, Bass AJ, Rosman DL, Smith MB, Semmens JB, Glasson EJ et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev 2008; 32: 766–777.

Almeida OP, Almeida SA . Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999; 14: 858–865.

Almeida OP, Alfonso H, Hankey GJ, Flicker L . Depression, antidepressant use and mortality in later life: the Health In Men Study. PLoS ONE 2010; 5: e11266.

WHO Collaborating Centre for Drug Statistics Methodology Guidelines for ATC Classification and DDD Assignment 2013. WHO Collaborating Centre for Drug Statistics Methodology: Oslo, Norway, 2012.

Fiest KM, Jette N, Roberts JI, Maxwell CJ, Smith EE, Black SE et al. The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis. Can J Neurol Sci 2016; 43 Suppl 1: S3–S50.

ABS 3412.0 - Migration, Australia, 2013-14. Australian Bureau of Statistics: Canberra, 2015.

Matthews FE, Stephan BC, Robinson L, Jagger C, Barnes LE, Arthur A et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun 2016; 7: 11398.

Prina AM, Huisman M, Yeap BB, Hankey GJ, Flicker L, Brayne C et al. Association between depression and hospital outcomes among older men. CMAJ 2013; 185: 117–123.

Stuart AL, Pasco JA, Jacka FN, Brennan SL, Berk M, Williams LJ . Comparison of self-report and structured clinical interview in the identification of depression. Compr Psychiatry 2014; 55: 866–869.

Blazer DG . Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003; 58: 249–265.

Takayanagi Y, Spira AP, Bienvenu OJ, Hock RS, Carras MC, Eaton WW et al. Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study. J Clin Psychiatry 2015; 76: 40–44.

Almeida OP, Alfonso H, Pirkis J, Kerse N, Sim M, Flicker L et al. A practical approach to assess depression risk and to guide risk reduction strategies in later life. Int Psychogeriatr 2011; 23: 280–291.

Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH . Depressive symptoms, sex, and risk for Alzheimer’s disease. Ann Neurol 2005; 57: 381–387.

Almeida OP, Ford AH, Hirani V, Singh V, vanBockxmeer FM, McCaul K et al. B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial. Br J Psychiatry 2014; 205: 450–457.

Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT . Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5: e45.

Mirza SS, de Bruijn RF, Direk N, Hofman A, Koudstaal PJ, Ikram MA et al. Depressive symptoms predict incident dementia during short- but not long-term follow-up period. Alzheimers Dement 2014; 10: S323–S329, e321.

van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H et al. Neuropsychiatric symptoms in a European Huntington’s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 2014; 85: 1411–1418.

Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR . Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 2003; 18: 414–418.

Almeida OP . Prevention of depression in older age. Maturitas 2014; 79: 136–141.